Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions

被引:148
作者
Franzoso, G
Carlson, L
SchartonKersten, T
Shores, EW
Epstein, S
Grinberg, A
Tran, T
Shacter, E
Leonardi, A
Anver, M
Love, P
Sher, A
Siebenlist, U
机构
[1] NIAID,IMMUNOREGULAT LAB,NIH,BETHESDA,MD 20892
[2] NIAID,PARASIT DIS LAB,NIH,BETHESDA,MD 20892
[3] NICHHD,MOL GENET LAB,NIH,BETHESDA,MD 20892
[4] US FDA,CTR BIOL EVALUAT & RES,DIV CELLULAR & GENE THERAPIES,BETHESDA,MD 20892
[5] SCI APPLICAT INT CORP,PATHOL HISTOTECHNOL LAB,FREDERICK,MD 21702
[6] NCI,FREDERICK CANC RES & DEV CTR,FREDERICK,MD 21702
关键词
D O I
10.1016/S1074-7613(00)80291-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chromosomal translocations of bcl-3 are associated with chronic B cell lymphocytic leukemias. Previously, we have shown that Bcl-3, a distinct member of the I kappa B family, may function as a positive regulator of NF-kappa B activity, although its physiologic roles remained unknown. To uncover these roles, we generated Bcl-3-deficient mice. Mutant mice, but not their littermate controls, succumb to T. gondii owing to failure to mount a protective T helper 1 immune response. Bcl-3-deficient mice are also impaired in germinal center reactions and T-dependent antibody responses to influenza virus. The results reveal critical roles for Bcl-3 in antigen-specific priming of T and B cells. Altered microarchitecture of secondary lymphoid organs in mutant mice, including partial loss of B cells, may underlie the immunologic defects. The implied role of Bcl-3 in maintaining B cells in wild-type mice may related to its oncogenic potential.
引用
收藏
页码:479 / 490
页数:12
相关论文
共 69 条
  • [1] Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen
    Ahearn, JM
    Fischer, MB
    Croix, D
    Goerg, S
    Ma, MH
    Xia, JR
    Zhou, XN
    Howard, RG
    Rothstein, TL
    Carroll, MC
    [J]. IMMUNITY, 1996, 4 (03) : 251 - 262
  • [2] BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
  • [3] The NF-kappa B and I kappa B proteins: New discoveries and insights
    Baldwin, AS
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 649 - 683
  • [4] EMBRYONIC LETHALITY AND LIVER DEGENERATION IN MICE LACKING THE RELA COMPONENT OF NF-KAPPA-B
    BEG, AA
    SHA, WC
    BRONSON, RT
    GHOSH, S
    BALTIMORE, D
    [J]. NATURE, 1995, 376 (6536) : 167 - 170
  • [5] CONSTITUTIVE NF-KAPPA-B ACTIVATION, ENHANCED GRANULOPOIESIS, AND NEONATAL LETHALITY IN I-KAPPA-B-ALPHA-DEFICIENT MICE
    BEG, AA
    SHA, WC
    BRONSON, RT
    BALTIMORE, D
    [J]. GENES & DEVELOPMENT, 1995, 9 (22) : 2736 - 2746
  • [6] EFFECTS OF IL-12 ON IMMUNE-RESPONSES TO MICROBIAL INFECTIONS - A KEY MEDIATOR IN REGULATING DISEASE OUTCOME
    BIRON, CA
    GAZZINELLI, RT
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (04) : 485 - 496
  • [7] THE ONCOPROTEIN BCL-3 DIRECTLY TRANSACTIVATES THROUGH KAPPA-B MOTIFS VIA ASSOCIATION WITH DNA-BINDING P50B HOMODIMERS
    BOURS, V
    FRANZOSO, G
    AZARENKO, V
    PARK, S
    KANNO, T
    BROWN, K
    SIEBENLIST, U
    [J]. CELL, 1993, 72 (05) : 729 - 739
  • [8] MADCAM-1 HAS HOMOLOGY TO IMMUNOGLOBULIN AND MUCIN-LIKE ADHESION RECEPTORS AND TO IGA1
    BRISKIN, MJ
    MCEVOY, LM
    BUTCHER, EC
    [J]. NATURE, 1993, 363 (6428) : 461 - 464
  • [9] EXPRESSION OF RELB IS REQUIRED FOR THE DEVELOPMENT OF THYMIC MEDULLA AND DENDRITIC CELLS
    BURKLY, L
    HESSION, C
    OGATA, L
    REILLY, C
    MARCONI, LA
    OLSON, D
    TIZARD, R
    CATE, R
    LO, D
    [J]. NATURE, 1995, 373 (6514) : 531 - 536
  • [10] Caamano JH, 1996, MOL CELL BIOL, V16, P1342